KTH Royal Institute of Technology, Department of Protein Science, Division of Systems Biology

Location: Stockholm, Sweden

Start Date: Upon agreement

Application Deadline: May 30th, 2025

We are pleased to a fully funded PhD position in experimental and data-driven cancer research as part of the KAW-DDLS Fellowship program. This positions is intended for motivated students with:

A second cycle degree (for example a master's degree) in Bioinformatics, Computational Biology, or related fields

In order to succeed as a doctoral student at KTH you need to be goal oriented and persevering in your work. During the selection process, candidates will be assessed upon their ability to:

independently pursue their work
collaborate with others
have a professional approach and
analyze and work with complex issues.
Additional qualifications include:
Research background in cancer biology
Prior experience with lab techniques such (e.g. cell culture, cellular imaging, Western blotting, qPCR, and lentiviral overexpression or silencing)
Experience working with cell lines, organoids, or zebrafish
Three references are required, including at least one from your current/previous supervisor.

Additional valuable skills:

Able to synthesize scientific literature
Demonstrated problem-solving abilities and attention to detail
A strong publication record in relevant fields
Proficiency in programming (e.g., R, Python, Bash)
Effective communication in English is required for daily work.

After the qualification requirements, great emphasis will be placed on personal skills.

Are you interested? Apply here:

Doctoral student in Experimental and Data-Driven Cancer Research

Precision medicine powered byData-Driven research

We're hiring.

Principal Investigator

PhD Student

PhD Student

Lundberg's lab has received Digital Futures Research Pairs grant!

Alexandra presented her work at the DDLS conference!

Lundberg's lab has been awarded the Swedish Research Council Starting Grant in Medicine and Health.

Prostatacancer Förbundet project grant

The Knut and Alice Wallenberg Foundation, Data-Driven Life Science Fellowship

Prostate Cancer Foundation Young Investigator Award

Early gonadotoxic effects of cyclophosphamide on the prepubertal testis and the feasibility of reducing toxicity through combined antioxidant therapy

Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

Elucidating acquired PARP inhibitor resistance in advanced prostate cancer

Genomic and Transcriptomic Features of Resistance to Androgen Receptor Signaling Inhibitors in Metastatic Castration-Resistant Prostate Cancer

Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer

Evaluating BCL2 as a biomarker and therapeutic target in advanced prostate cancer with lineage plasticity

An Atlas of Accessible Chromatin in Advanced Prostate Cancer

Interactions between the 3D-genome and DNA, RNA, and epigenomic alterations in metastatic prostate cancer

Integrative analysis of ultra-deep RNA-seq reveals activation of alternative promoters by oncogenic drivers and DNA hypomethylation during prostate tumor progression

The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

Precision medicine powered byData-Driven research

We're hiring.

Principal Investigator

PhD Student

PhD Student

Lundberg's lab has received Digital Futures Research Pairs grant!

Alexandra presented her work at the DDLS conference!

Lundberg's lab has been awarded the Swedish Research Council Starting Grant in Medicine and Health.

Prostatacancer Förbundet project grant

The Knut and Alice Wallenberg Foundation, Data-Driven Life Science Fellowship

Prostate Cancer Foundation Young Investigator Award

Early gonadotoxic effects of cyclophosphamide on the prepubertal testis and the feasibility of reducing toxicity through combined antioxidant therapy

Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

Elucidating acquired PARP inhibitor resistance in advanced prostate cancer

Genomic and Transcriptomic Features of Resistance to Androgen Receptor Signaling Inhibitors in Metastatic Castration-Resistant Prostate Cancer

Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer

Evaluating BCL2 as a biomarker and therapeutic target in advanced prostate cancer with lineage plasticity

An Atlas of Accessible Chromatin in Advanced Prostate Cancer

Interactions between the 3D-genome and DNA, RNA, and epigenomic alterations in metastatic prostate cancer

Integrative analysis of ultra-deep RNA-seq reveals activation of alternative promoters by oncogenic drivers and DNA hypomethylation during prostate tumor progression

The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

Precision medicine powered by
Data-Driven research

Precision medicine powered by
Data-Driven research